MedTrace Logo

Malaria Active Epidemiology and Treatment Study

NCT01280162 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2021-03-03

No results posted yet for this study

Summary

An observational cohort and malaria treatment study in Cambodia.

Conditions

Interventions

DRUG

Dihydroartemisinin piperaquine

40/320 mg tablets, 9 tablets total

Sponsors & Collaborators

  • United States Army Medical Materiel Development Activity

    collaborator FED

  • Armed Forces Research Institute of Medical Sciences, Thailand

    lead OTHER_GOV

Principal Investigators

  • Michele D. Spring, MD, MSPH · USAMC-AFRIMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-02-28
Completion
2012-12-31

Countries

  • Cambodia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01280162 on ClinicalTrials.gov